-
Perospirone: Receptor and Kv1.5 Research Workflows
2026-09-15
Perospirone (SM-9018 free base) supports receptor-focused schizophrenia research while enabling a complementary investigation of vascular Kv1.5 channel inhibition. This guide translates its chemistry and pharmacology into practical assay workflows, controls, and troubleshooting strategies for neuropsychiatric and cardiovascular research.
-
Separating Growth Inhibition from Cell Death
2026-09-15
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for distinguishing proliferative arrest from cell killing, improving the interpretation of potency, timing, and mechanism in cancer biology research.
-
ML133 HCl Workflow for Kir2.1 Research
2026-09-14
ML133 HCl is a selective potassium channel inhibitor for connecting Kir2.1 activity with potassium ion transport, PASMC behavior, and vascular-remodeling signals. This practical guide translates published findings into concentration planning, assay workflows, controls, and troubleshooting decisions.
-
APEX2 Promotes Efficient TERT Expression in hESCs
2026-09-14
A bioRxiv study identifies APEX2, but not its paralog APEX1, as a determinant of efficient TERT expression and telomerase activity in human embryonic stem cells and melanoma cells. RNA sequencing and chromatin immunoprecipitation connect this effect to APEX2 occupancy near repeat elements, especially MIR sequences within TERT intron 2, suggesting a DNA repair–transcription interface.
-
MK-1775: Wee1 Kinase Inhibitor Workflow Guide
2026-09-13
Use MK-1775 to interrogate Wee1-dependent cell-cycle control, distinguish growth arrest from cell death, and test chemotherapy sensitization in p53-deficient cancer models. This workflow emphasizes time-resolved controls, quantitative viability metrics, and troubleshooting for reproducible checkpoint-abrogation studies.
-
Dexamethasone (DHAP) Research Workflows
2026-09-12
Dexamethasone (DHAP) supports controlled studies of NF-κB modulation, stem cell differentiation, autophagy, osteosarcoma growth, and neuroinflammation. This practical guide connects formulation, time-course design, route comparisons, and troubleshooting to improve assay reproducibility.
-
Better In Vitro Drug Response Metrics in Cancer
2026-09-12
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to clarify whether an anticancer treatment mainly suppresses proliferation, induces cell death, or does both. The framework emphasizes measuring response magnitude and timing separately, improving interpretation of in vitro drug studies and their translation to mechanistic models.
-
Dihydroethidium (DHE): Reliable Superoxide Assays
2026-09-11
This scenario-driven guide explains how Dihydroethidium (DHE), SKU C3807, can support reproducible live-cell superoxide measurements alongside viability, proliferation, and cytotoxicity assays. It covers spectral selection, controls, solvent and storage constraints, interpretation limits, and practical vendor-selection criteria.
-
U0126 for MEK1/2 and Mechanobiology Studies
2026-09-11
Use U0126 to test whether mechanical cues, growth signals, or disease-associated stimuli depend on MEK1/2–ERK activation. Its cell permeability and non-ATP-competitive profile make it especially useful for connecting pathway inhibition with morphology, mineralization, autophagy, and survival readouts.
-
Angiotensin II, Cx43, and M1 Macrophage Polarization
2026-09-10
The reference study connects angiotensin II exposure with M1-like polarization of RAW264.7 macrophages through a connexin 43 and NF-κB/p65 signaling axis. Its combined use of pathway inhibition, Cx43-directed inhibitors, and orthogonal inflammatory readouts provides a useful framework for studying how gap-junction proteins influence macrophage-mediated cardiovascular inflammation.
-
SCH772984 HCl: ERK1/2 Workflow Guide
2026-09-10
SCH772984 HCl enables precise ERK1/2 inhibition across phospho-signaling, proliferation, resistance, and stem-cell chromatin assays. This practical guide connects nanomolar pathway control with workflow design for BRAF- or RAS-driven models and TERT regulation studies.
-
L-Phenylephrine α1A Signaling Workflows
2026-09-09
L-Phenylephrine provides a practical entry point for dissecting α1A-linked vascular, cardiac, neural, and baroreflex responses. This workflow-focused guide translates sex-aware hypertension findings into reproducible dose-response assays, controls, and troubleshooting strategies.
-
APEX2 Supports TERT Expression in Human Stem Cells
2026-09-09
A 2024 bioRxiv preprint identifies APEX2, but not its paralog APEX1, as a contributor to efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma model. RNA sequencing and chromatin immunoprecipitation connect this effect to APEX2 occupancy near repetitive MIR elements within the TERT locus, suggesting that DNA repair at damage-prone repeats may influence gene expression.
-
MK-1775: Wee1 Kinase Inhibitor Workflows
2026-09-08
Use MK-1775 to connect Wee1 inhibition with checkpoint biology, chemotherapy sensitization, and cell-fate measurement. This workflow separates growth arrest from cell death so responses in p53-deficient models are interpreted rather than overcalled.
-
5-Methyl-CTP for Robust mRNA Workflows
2026-09-07
Learn how 5-Methyl-CTP can be integrated into in vitro transcription workflows to screen for stronger RNA integrity and translation performance. A lactating-cow H5N1 mRNA vaccine study provides a practical translational benchmark while highlighting why reagent-level optimization and product-level efficacy must remain distinct.